Literature DB >> 3740844

Separation and partial sequence analysis of blood group A-active oligosaccharides by affinity chromatography using monoclonal antibodies.

J Dakour, G C Hansson, A Lundblad, D Zopf.   

Abstract

An affinity column containing an anti-blood group A monoclonal antibody coupled to Sepharose beads specifically retards oligosaccharides with the nonreducing trisaccharide sequence GalNAc alpha 1-3(Fuc alpha 1-2)Gal beta 1-R. Three A-active oligosaccharides, A-tetra, A-penta, and A-hepta, elute as retarded peaks, well-separated from unbound sugars. A-hepta, which contains a difucosylated type 1 (Leb) core structure, elutes much later than A-tetra or A-penta and can be completely separated from the latter oligosaccharides by affinity chromatography. The order of elution of the oligosaccharides agrees with their previously determined specific molar activities as inhibitors of quantitative immune precipitation [H.-T. Chen, and E. A. Kabat, (1985) J. Biol. Chem. 260, 13208-13217]. Treatment of A-hepta with Charonia lampas alpha-galactosaminidase abolishes its binding by the anti-A affinity column and converts it to a Leb-active oligosaccharide (lacto-N-difucohexaose I) that is specifically retarded on a second affinity column containing an anti-Leb monoclonal antibody.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3740844     DOI: 10.1016/0003-9861(86)90522-9

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

1.  Single mid-chain GlcNAc beta 1-6Gal beta 1-4R sequences of linear oligosaccharides are resistant to endo-beta-galactosidase of Bacteroides fragilis.

Authors:  O Renkonen; L Penttilä; R Niemelä; A Leppänen
Journal:  Glycoconj J       Date:  1991-08       Impact factor: 2.916

2.  Affinity purification of monoclonal antibodies, using a bifunctional oligosaccharide hapten.

Authors:  S Uppugunduri; J Dakour; E Kallin; T Norberg; D Zopf; A Lundblad
Journal:  Glycoconj J       Date:  1991-04       Impact factor: 2.916

Review 3.  The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human.

Authors:  Anthony P Corfield
Journal:  Microorganisms       Date:  2018-08-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.